EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Profit After Tax (2010 - 2026)

EyePoint (EYPT) posted Profit After Tax of -$84.8 million for Q1 2026, down 25.47% sequentially from -$67.6 million in Q4 2025, and down 87.27% YoY from -$666.2 million in Q1 2025.

Analysis

EyePoint (EYPT) Profit After Tax (2010 - 2026) Analysis & Trends

EyePoint has reported Profit After Tax for 17 years, with the latest figure at -$84.8 million in Q1 2026.

  • Quarterly Profit After Tax fell 87.27% year-over-year to -$84.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$271.6 million (down 85.0% YoY) and the FY2025 annual result came in at -$232.0 million, down 77.25% from the prior year.
  • Profit After Tax retreated to -$84.8 million in Q1 2026 per EYPT's latest filing, from -$67.6 million in the prior quarter.
  • Over five years, Profit After Tax peaked at -$12.6 million in Q3 2023 and troughed at -$84.8 million in Q1 2026.
  • A 5-year average of -$36.5 million and a median of -$29.3 million in 2024 frame the typical range for Profit After Tax.
  • The sharpest annual moves came in 2023 and 2024: Profit After Tax surged 67.65% in 2023, then tumbled 196.29% in 2024.
  • Over 5 years, Profit After Tax stood at -$43.5 million in 2022, then soared by 67.65% to -$14.1 million in 2023, then sank by 196.29% to -$41.7 million in 2024, then plunged by 62.11% to -$67.6 million in 2025, then retreated by 25.47% to -$84.8 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$84.8 million, -$67.6 million, and -$59.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -16.62 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00 -94.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -94.48 Mn
Mar 31, 2026 -84.99 Mn
Dec 31, 2025 -67.57 Mn
Sep 30, 2025 -59.73 Mn
Jun 30, 2025 -59.52 Mn
Mar 31, 2025 -45.30 Mn
Dec 31, 2024 -41.40 Mn
Sep 30, 2024 -29.36 Mn
Jun 30, 2024 -30.87 Mn
Mar 31, 2024 -29.31 Mn
Dec 31, 2023 -14.10 Mn
Sep 30, 2023 -12.61 Mn
Jun 30, 2023 -22.92 Mn
Mar 31, 2023 -21.16 Mn
Dec 31, 2022 -43.32 Mn
Sep 30, 2022 -18.42 Mn
Jun 30, 2022 -19.59 Mn
Mar 31, 2022 -21.03 Mn
Dec 31, 2021 -19.43 Mn
Sep 30, 2021 -16.70 Mn